And not for nothing, but aren't all of these patients
And not for nothing, but aren't all of these patients likely taking these cheaper & available drugs as part of their standard of care treatment during the course of their disease? Wouldn't that have an effect on the fog that seems to be lingering in so many patients? I like the idea of accessible and cheap options for long haulers but it doesn't seem as easy as just throwing steroids and HCQ at patients.
Often you'll see articles come out about some exciting new information around a disease. The headlines are promising and then when you read the article you realize the authors just did a deep dive into studies that have already been done, compiling them all together in a meta analysis to uncover or show some new trend or correlation between result and medication. While this can be a useful exercise, the reality is that you just don't know until you do a specific trial against your hypothesis. Longhaulers are a real, significant problem and if Leronlimab shows in a trial that it works on those patients it would be the first and only proven option. It would be a very valuable tool for doctors and get widespread use. If in the paper Dr. Yo and Dr. BP put together their analysis and the science is sound, that's great. There could be some off label use and hopefully it would generate enough interest to run some actual trials. I think there's a place for both and one doesn't diminish the potential of the others.
As an aside, while I am very excited at the possibility of having lots of money from this drug getting approved, I'm slowly becoming more excited at knowing that every time my stomach rumbles I don't have to wonder if it's early 'Rona percolating in my belly first before spreading to my taste buds. Thinking that it's odd my ankle isn't getting that much better after I forgot there was one more step off my deck the other day and is it possible that the girl across the street saw me stumble for a second because while I'm married and it shouldn't matter if I look stupid in front of an attractive neighbor I still like to pretend I'm a catch and not an ageing parent with a growing dad bod but really I'm just worried that the virus could be attacking my already weakened ankle and working it's way up my body toward my taste buds and OMG MY MANHOOD IS ON THAT PATH SHOULD I BE WORRIED WHAT DOES JEEVES SAY SOMEONE ASK JEEEEEEVVVVEEEEEEES!
I guess what I'm saying is I'm just not ready to start doing real work in my home office yet today. Oh, and I do think Leronlimab will work wonderfully in longhaulers.
10
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...
Continue Reading
Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...
Continue Reading
Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...
Continue Reading
America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...
Continue Reading
Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...
Continue Reading
AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...
Continue Reading
Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...
Continue Reading
AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...
Continue Reading
Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...
Continue Reading
Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...
Continue Reading
Top 5 Most Recently Viewed Articles
Intelligent Product Solutions Celebrated for Design Excellence Intelligent Product Solutions (IPS) has recently achieved remarkable recognition for its innovative design work on the EON Laser, a pioneering device in the realm of aesthetic treatments. This honor was awarded at the esteemed New York Product Design Awards, acknowledging IPS for their pivotal role in...
Continue Reading
EverLine Coatings Celebrates Growth in the Franchise Industry EverLine Coatings has proudly acknowledged 2024 as a significant year characterized by strategic growth and expanded services across North America. This line striping and pavement maintenance franchise has achieved numerous milestones that further solidify its stature within the industry. Over the course of the...
Continue Reading
Introducing NESCAFÉ® Espresso Concentrate The world of coffee has taken an exciting turn with the launch of NESCAFÉ® Espresso Concentrate, the first liquid concentrate from NESCAFÉ®. This innovative product offers coffee aficionados a simple yet effective way to create café-style iced espresso beverages right from their homes. With NESCAFÉ® Espresso Concentrate,...
Continue Reading
Jungbunzlauer Introduces Magnesium Bisglycinate Jungbunzlauer, a prominent name in the realm of sustainable ingredients, is pleased to announce a groundbreaking addition to its mineral portfolio. The company will be featuring its newly developed fully-reacted magnesium bisglycinate at SupplySide Global 2025 in Las Vegas. This debut is a testament to Jungbunzlauer’s...
Continue Reading
JVM Realty Corp. Expands Portfolio with Mayfair Reserve Acquisition JVM Realty Corp., a recognized leader in multifamily real estate investment and property management, has recently announced its acquisition of Mayfair Reserve. This stunning 236-unit luxury apartment community adds an impressive asset to their already flourishing portfolio. Strategic Acquisition in a...
Continue Reading